EWTXEdgewise Therapeutics, Inc.

$39.02+174% 1Y

Is the business good?

How good a business is EWTX?

Share count, year on year
+2.6%

Share count, year on year · shareholders own a smaller slice than a year ago

Details›
Free cash flow, trailing twelve months
−$159M
Net income, trailing twelve months
−$197M

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.